Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next?
by Tristan Rich · The Markets DailyPredictive Oncology Inc. (NASDAQ:POAI – Get Free Report) shares crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $6.15 and traded as low as $4.11. Predictive Oncology shares last traded at $4.50, with a volume of 897,987 shares.
Predictive Oncology Trading Down 17.8%
The company has a market cap of $13.51 million, a price-to-earnings ratio of -0.29 and a beta of 1.35. The firm has a 50-day moving average price of $2.35 and a 200 day moving average price of $6.06.
Predictive Oncology Company Profile
Predictive Oncology, Inc is a biotechnology company that leverages artificial intelligence and digital biology to support drug discovery and development in oncology. Its core business revolves around the application of machine learning algorithms to high-content cellular imaging, multi-omic profiling, and clinical response data. By integrating these diverse data streams, the company aims to generate predictive models that forecast the efficacy and toxicity of candidate therapeutics, thereby accelerating preclinical decision-making and reducing development timelines.
The company’s primary offerings include its Phenomics platform, which combines automated microscopy with advanced image analysis to capture subtle phenotypic changes in cancer cells.